Advancing translational life sciences research and academic technology transfer

BioStrategy Partners recently hosted two highly informative in-person events, exploring essential topics in the life sciences industry. The events attracted industry leaders, C-suite executives, business development leaders, academic researchers, consultants, tech transfer professionals, and graduate students to engage with expert panelists on dilutive funding  and finding lab space for your startup.

The dilutive funding event hosted at The Wistar Institute provided valuable insights into securing necessary investments for early-stage companies, highlighting best practices and resources available. The advantages and disadvantages of dilutive funding were explored, highlighting the trade-offs involved in accepting outside investment versus maintaining full control. Attendees gained valuable insights into identifying and approaching potential investors, perfecting pitches, as well as leveraging various resources, assets and funding models to lead your startup to success. Watch video here

Speakers (Left to Right): Kathie Jordan, Lorenzo Pellegrino, Rick Jones, Michele Washko.

The biotech laboratory event hosted at Thomas Jefferson University explored the diverse options for laboratory spaces, emphasizing essential considerations and discussing the unique features of traditional incubators, SmartLabs, and the Center for Diagnostic Discovery. Attendees explored the diverse options available, ranging from traditional laboratories to cutting-edge SmartLabs and the Center for Diagnostic Discovery. Key considerations when choosing a lab space were discussed, including infrastructure, equipment availability, flexibility, proximity to research hubs, and potential collaborations. The event highlighted the incentives offered to attract biotech tenants, such as specialized support services, shared resources, and networking opportunities. Watch Video Here

Speakers (Left to Right): Matt Gardner, Daisy Riquelme, Art Howe, Eric Rieders

By facilitating knowledge exchange and fostering connections among industry professionals, BioStrategy Partners continues to contribute to the growth and success of the life sciences biotech/startup community.

Join BioStrategy Partners at this in-person event hosted at Thomas Jefferson University (901 Walnut St.) Don’t miss out on this BioStrategy Partner’s Practical Knowledge Series event to network with leading experts in our region for a discussion on biotech incubators and finding the best fit for your company and technology. Register here

A biotech incubator provides access to infrastructure, resources, and a collaborative environment, which can be the difference between success and failure in this competitive industry. Our expert panelists will share their extensive knowledge on different types of incubators and laboratory-as-a-service options, their functionality, advantages, and all the resources they offer tenants. You’ll learn about shared labs in Greater Philadelphia, including SmartLabs and the Center for Diagnostic Discovery.

We thank our sponsors SmartLabs and CBRE for hosting this event.

Wednesday, October 28, 2020, 4:00 - 5:00 P.M.

 
Mark your calendar for Wistar's upcoming in-depth discussion with President and CEO Dr. Dario Altieri. He will review our important cancer research progress, local and global education initiatives, and how our history and expertise in pandemic preparedness has positioned us to address today's global health threats.

Please register below for this special virtual event and submit your questions via the registration page. We will respond to as many as possible during the program.

REGISTER TODAY

 

The event is free and open to the public. Feel free to share this invite with family or friends.

 

Duke-NUS Medical School, Singapore’s research-intensive, graduate-entry medical school, has joined BioStrategy Partners Inc. (BioSP), a consortium of academic institutions that collaborate with industry partners to scale academic discoveries and bring new treatments, diagnostics and other products to patients worldwide.

Other consortium members include the Children’s Hospital of Philadelphia, The Pennsylvania State University, Temple University, Thomas Jefferson University, The Wistar Institute and University of the Sciences. Duke-NUS is the consortium’s first non-US-based member.

As a member of the consortium, Duke-NUS will participate in BioSP’s Germinator program, which partners with pharmaceutical and medical device companies to identify and de-risk promising academic projects through a coordinated process, including organized sessions with industry-based scientific and commercial experts. The result is a joint development plan and funding, as well as intellectual exchanges and other forms of engagement with industry-based scientists.

“BioSP is excited to welcome into the consortium Duke-NUS, which has established a solid reputation for world-class research. Our members, industry partners and, ultimately, patients stand to benefit from the multinational perspective Duke-NUS will bring,” said Erika Swift, President of BioSP.

“Finding mechanisms to create long-term, substantive relationships with industry is a key strategy for Duke-NUS’s innovation and entrepreneurship program,” said Associate Professor Christopher Laing, Senior Associate Dean for Innovation and Entrepreneurship at Duke-NUS. “Universities are great at discovery – but we need industry partners to scale our impact. Organisations like BioSP help us to amplify our collaborative reach.”

In addition to participating in the Germinator programme, BioSP consortium members, which collectively perform more than US$1 billion of annual biomedical research and development, share best practices and expertise for commercialization, and provide shared educational resources to scientists across their institutions.

 About Duke-NUS Medical School

 For more information, please visit www.duke-nus.edu.sg

For media inquiries, please contact:

Michele Washko
admin@biostrategypartnes.org
Tel: 717-514-0436

 

A new study by led by Children’s Hospital of Philadelphia (CHOP) has found that neighborhood violent crime is associated with high levels of perceived stress in pregnancy. The study, published in the International Journal of Environmental Research and Public Health, also found that even though the results held up regardless of race, Black women were significantly more likely to live in neighborhoods with high levels of violent crime and were more likely to report high perceived stress than non-Black women.

<<FULL STORY>>

A team of researchers at Children’s Hospital of Philadelphia (CHOP) affiliated with the CHOP Epilepsy Neurogenetics Initiative (ENGIN) further bridged the gap between genomic information and clinical outcome data by systematically linking genetic information with electronic medical records, focusing on how genetic neurological disorders in children develop over time. The findings were published today in the journal Genetics in Medicine.

<<FULL STORY>>

More than three-quarters of the patients in Penn State Health Milton S. Hershey Medical Center’s Cardiac Rehabilitation Program find their depression decreases, half of patients see their strength nearly doubled and 80% of patients meet their blood pressure goal of 130/80 or lower.

<<FULL STORY>>

According to a study by The Wistar Institute, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells. These messages are packaged into particles called extracellular vesicles (EVs) and reprogram mitochondrial shape and position within the recipient normal cells to ultimately promote deregulated tissue morphogenesis. These findings were published today in Developmental Cell.

<<FULL STORY>>

Dr. Maureen  Murphy, Ira Brind Professor and program leader of the Molecular & Cellular Oncogenesis Program of The Wistar Institute Cancer Center, has been investigating the importance of inherited mutations in the gene encoding p53 tumor suppressor protein to determine cancer susceptibility in people of African descent and people of Ashkenazi Jewish descent, for the past twenty-two years.

<<FULL STORY>>

Women carrying twins are at higher risk for premature birth and miscarriage – those whose cervix dilates before 24 weeks are at highest risk – and yet one common treatment is not recommended for this population. A new multi-center randomized-controlled trial from Thomas Jefferson University shows that cerclage, an intervention that sutures a dilating cervix closed, can help prevent preterm birth and miscarriage. The findings could overturn existing guidelines.

<<FULL STORY>>